English | 繁體

Search in the results

UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China Journal article
Ruan, Zhen, Chen, Xianwen, Song, Menghuan, Jia, Ruxu, Luo, Hang, Ung, Carolina Oi Lam, Hu, Hao. Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China[J]. Diabetes, Metabolic Syndrome and Obesity, 2024, 17, 3657-3666.
Authors:  Ruan, Zhen;  Chen, Xianwen;  Song, Menghuan;  Jia, Ruxu;  Luo, Hang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.8/3.3 | Submit date：2024/11/05
Type 2 Diabetes Mellitus  Glucagon-like Peptide-1 Receptor Agonist  Glp-1ra  Retrospective  China  Electronic Medical Record  Real-world  
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review Journal article
Zhen Ruan, Yixuan Jiang, Honghao Shi, Ruxu Jia, Carolina Oi Lam Ung, Hao Hu. Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review[J]. Expert Review of Clinical Pharmacology, 2023, 16(2), 161-176.
Authors:  Zhen Ruan;  Yixuan Jiang;  Honghao Shi;  Ruxu Jia;  Carolina Oi Lam Ung; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:3.6/4.1 | Submit date：2023/08/03
Effectiveness  Glp-1ra  Hba1c  O.w. Semaglutide  Type 2 Diabetes  Real-world Evidence  Review  Weight  
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China Journal article
Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China[J]. Diabetes Therapy, 2023, 14(1), 93-107.
Authors:  Liu, Lei;  Ruan, Zhen;  Ung, Carolina Oi Lam;  Zhang, Yawen;  Shen, Yang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2023/01/08
Cost-effectiveness Analysis  Type 2 Diabetes  Glucagon-like Peptide-1 Analogue  Semaglutide  Peg-loxenatide  China